Oral contraceptives alone and with spironolactone increase sCD40 ligand in PCOS patients

Kebapcilar, Levent; Bilgir, Oktay; Taner, Cuneyt; Kebapcilar, Ayse; Kozaci, Didem; Alacacioglu, AHMET; Yildiz, Yasar; Yuksel, Arif; SARI, İSMAİL

doi:10.1007/s00404-009-1189-7

Oral contraceptives alone and with spironolactone increase sCD40 ligand in PCOS patients

Atıf İçin Kopyala

Kebapcilar L., Bilgir O., Taner C. E., Kebapcilar A. G., Kozaci D. L., Alacacioglu A., ...Daha Fazla

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, cilt.281, sa.3, ss.539-543, 2010 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 281 Sayı: 3
Basım Tarihi: 2010
Doi Numarası: 10.1007/s00404-009-1189-7
Dergi Adı: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.539-543
Anahtar Kelimeler: sCD40L, Ethinylestradiol, Cyproterone acetate, Spironolactone, PCOS, POLYCYSTIC-OVARY-SYNDROME, SYSTEMIC-LUPUS-ERYTHEMATOSUS, CARDIOVASCULAR RISK, ENDOTHELIAL-CELLS, CD40 LIGAND, T-CELLS, EXPRESSION, ESTROGEN, FIBRINOLYSIS, ACTIVATION
Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

The present study was designed to determine the effect of oral contraceptives (OCP) and OCP plus spironolactone (Sp) on plasma soluble CD40L levels in polycystic ovary syndrome (PCOS) patients.